Retrolental fibroplasia-an end stage of pediatric retinal diseases

Joint Event on 23rd Edition of Advancements in Ophthalmology: Clinical & Surgical Practices & 24th Edition of International Conference on Ophthalmology Case Reports
July 30-August 01, 2018 Barcelona, Spain

Xuefeng Feng and Zhizhong Ma

Peking University Third Hospital, China

Posters & Accepted Abstracts: Insights in Ophthalmology

Abstract

Retrolental fibroplasia (RLF) was first described by Terry as a mass of vascular embryonic connective and retinal tissues observed behind the lens in eyes of infants of premature birth in 1942; latter on it came to be known as the sign of the end stage of retinopathy of prematurity (ROP). In clinical practice, we recognized a variety of pediatric retinal diseases presented as RLF, including persistent fetal vasculature (PFV), ocular toxocariasis, coats disease, and ROP. Vitreoretinal surgery was performed for those RLF cases (16 eyes of 8 cases). The surgical outcome of RLF was bad, the characteristics of the RFL was summarized, and the surgical techniques was recommended.